T1	Participants 54 114	young adults with childhood-onset growth hormone deficiency.
T2	Participants 160 207	young adults with childhood-onset GH deficiency
T3	Participants 440 508	young adults with childhood-onset growth hormone deficiency (CO GHD)
T4	Participants 734 797	Patients (n = 160; mean age, 21.2 years; 63% males) with CO GHD
